PDB30 COST-EFFECTIVENESS ANALYSIS OF THE DIABETES MEDICATIONS IN MEDICARE WITH SASdoi:10.1016/S1098-3015(10)72277-4XWangSDOSValue in Health
We thus interpreted our estimate as a lower bound for the overall financial burden. Finally, data of kidney function or proteinuria, information on medications used, utilization of care in community health facilities, and out-of-hospital death were not available in our dataset....
Fourth, semaglutide and liraglutide as GLP-1 agonists can help improve diabetes outcomes. While these benefits are less relevant for adolescents than for adults and our model did not capture them explicitly, these benefits are indirectly captured through changes in annual health care costs and ...
Purpose: Inadequate type 2 diabetes management has a substantial economic burden in the United States. Currently, metformin is commonly prescribed as the first-line drug in type 2 diabetes. However, monotherapy is often insufficient, and addition of a second oral agent is required to maintain glyce...
“cost-effective” (< 3 times the GDP/capita) threshold for most patients, and some patients were even in the “highly cost-effective” range, such as patients with higher-risk factor levels (diabetes, baseline SBP ≥ 180 mm Hg, total cholesterol ≥ 6.2 mmol/L, or folate < ...
Adherence to medication, dietary and physical activity recommendations: Findings from a multicenter cross‐sectional study among adults with diabetes in ru... Background: Diabetes is a complex health condition requiring medical therapy and lifestyle modifications to attain treatment targets. Previous studi...
Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study) Article Open access 05 July ...
Patients who were dispensed with medications belonging to the ATC code A10 were deemed to have diabetes, as has been done in previous studies19,20. Model and modelled population A decision analytic transition Markov model with one-year cycles was developed to compare the health and economic ...
However, intensive control with oral medications was beneficial on average at all ages and had an ICER ≤$100,000 to age 70.CONCLUSIONS—The cost-effectiveness of intensive glucose control in older patients with new-onset diabetes is highly sensitive to assumptions regarding quality of life with ...
improved physical functioning,45 higher patient satisfaction with care,10 decreased burden from pain in the 1001 IMPACT patients with depression and comorbid osteoarthritis,46 increased adherence to exercise regimens, and improved physical functioning in the approximately 400 patients with type 2 diabetes ...